[
    [
        {
            "time": "",
            "original_text": "沃森生物：目前处于临床研究阶段的产品包括九价HPV疫苗、新冠mRNA疫苗等",
            "features": {
                "keywords": [
                    "沃森生物",
                    "九价HPV疫苗",
                    "新冠mRNA疫苗",
                    "临床研究"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "沃森生物：目前处于临床研究阶段的产品包括九价HPV疫苗、新冠mRNA疫苗等",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "沃森生物：公司目前共有7个疫苗产品（9个品规）生产上市",
            "features": {
                "keywords": [
                    "沃森生物",
                    "疫苗产品",
                    "生产上市"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物：公司目前共有7个疫苗产品（9个品规）生产上市",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "沃森生物：与艾博生物合作新型新型冠状病毒mRNA疫苗和带状疱疹mRNA疫苗",
            "features": {
                "keywords": [
                    "沃森生物",
                    "艾博生物",
                    "新冠mRNA疫苗",
                    "带状疱疹mRNA疫苗",
                    "合作"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "沃森生物：与艾博生物合作新型新型冠状病毒mRNA疫苗和带状疱疹mRNA疫苗",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]